Early Dual versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack: An Updated Systematic Review and Meta-Analysis

Ka Sing Lawrence Wong, Yilong Wang, Xinyi Leng, Chen Mao, Jinling Tang, Philip M. W. Bath, Hugh S. Markus, Philip B. Gorelick, Liping Liu, Wenhua Lin, and Yongjun Wang
Circulation. Originally published September 12, 2013.

For patients with acute non-cardioembolic ischemic stroke or TIA, dual therapy was more effective than monotherapy in reducing risks of early recurrent stroke.”